[1] Leon M B, Smith C R, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery[J]. N Engl J Med, 2010, 363(17): 1597-1607. [2] Andersen H R, Knudsen L L, Hasenkam J M. Transluminal implan-tation of artificial heart valves: Description of a new expand-able aortic valve and initial results with implantation by catheter technique in closed chest pigs[J]. Eur Heart J, 1992, 13(5): 704-708. [3] Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description[J]. Circulation, 2002, 106(24): 3006-3008. [4] Grube E, Laborde J C, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study[J]. Circulation, 2006, 114(15): 1616-1624. [5] FDA. The Edwards SAPIEN THV transcatheter heart valve system for patients with severe aortic stenosis who are not candidates for conventional open-heart aortic valve replacement surgery [EB/OL]. (2011-07)[2014-06-20]. http://www.fda.gov/downloads/advisoryco-mmittees/committeesmeetingmaterials/medicaldevices/medicaldev-icesadvisorycommittee/circulatorysystemdevicespanel/ucm262935.pdf. [6] FDA. Summary of safety and effectiveness data [EB/OL]. (2014-01)[2014-06-20]. http://www.accessdata.fda.gov/cdrh_docs/pdf13/P130021b.pdf. [7] Boston Scientific announces first commercial implants of the Lotus valve system in Europe [EB/OL]. (2013-11-15)[2014-06-20]. http://news.bostonscientific.com/2013-11-15-Boston-Scientific-Announces-First-Commercial-Implants-Of-T-he-Lotus-Valve-System-in-Europe. [8] Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012)[J]. Eur Heart J, 2012, 33(19): 2451-2496. [9] Leon M B, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium[J]. Eur Heart J, 2011, 32(2): 205-217. [10] NICE. Transcatheter aortic valve implantation for aortic stenosis [EB/OL].(2012-03)[2014-06-20]. http://guidance.nice.org.uk/IPG421/PublicInfo/pdf/English. [11] Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European association of cardio-thoracic surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)[J]. EuroIntervention, 2008, 4(2): 193-199. [12] Kappetein A P, Head S J, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document[J]. EuroIntervention, 2012, 8(7): 782-795. |